A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department

Pas encore traduit Pas encore traduit
Catégorie Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
Loading references information
The purpose of the study is to evaluate that low risk Pulmonary Embolism (PE) participants who are discharged from the Emergency Department (ED) to the home environment and treated with rivaroxaban as outpatients have fewer total days in the hospital for bleeding and/or venous thromboembolism (VTE) events through Day 30 compared to participants who are treated with initial hospitalization and standard-of-care.
Epistemonikos ID: 78180f4503c45dc92981bea25b99d805d2c2e1bf
First added on: Jun 19, 2023